Skip to main content
HOPA Abstracts, Colorectal Cancer
Encorafenib plus Cetuximab, with or without Binimetinib, for BRAF V600E–Positive Metastatic Colorectal Cancer: Relationship Between Carcinoembryonic Antigen and Clinical Outcomes from BEACON CRC
Abstract #CT06
Read More
HOPA Abstracts, Cost of Care
Cost of Cancer Management by Stage of Diagnosis Among Medicare Beneficiaries
Abstract #CT05
Read More
HOPA Abstracts, Multiple Myeloma
Corticosteroid Tapering in Patients with Relapsed or Refractory Multiple Myeloma Receiving Subcutaneous Daratumumab: Part 3 of the Open-Label, Multicenter, Phase 1b PAVO Study
Abstract #CT04
Read More
HOPA Abstracts, Targeted Therapies, Screening
Correlation of BRAF Mutation Status in Circulating Tumor DNA with Tumor Biopsy and Clinical Outcomes in the COLUMBUS Study
Abstract #CT03
Read More
HOPA Abstracts, Multiple Myeloma
Continuous Pre-Dose Assessment of Laboratory Parameters Is Not Required for Patients with Multiple Myeloma Receiving Lenalidomide, Bortezomib, and Dexamethasone
Abstract #CT02
Read More
Breast Cancer, FDA Updates
FDA Approves Margenza for Treatment of Metastatic HER2-Positive Breast Cancer
Read More
Original Research, Infusion Issues, Multiple Myeloma
Optimizing Daratumumab Infusion: Assessing the Safety and Feasibility of Omitting Preinfusion Medications and Decreasing Infusion Time
Justine Preedit, PharmD, Anya Yudchyts, PharmD, BCOP
Justine Preedit, PharmD; Anya Yudchyts, PharmD, BCOP
Read More
Case Reports, Dose Escalation/Reduction, Leukemia
Optimizing Response to Enasidenib with Dose Escalation in Relapsed or Refractory Acute Myeloid Leukemia
Amany R. Keruakous, MD, Sarah A. Schmidt, PharmD, Marcus T. Autry, PharmD, Julia Ye, PharmD Candidate, Phoi Nguyen, PharmD Candidate, Silas Day
Amany R. Keruakous, MD; Sarah A. Schmidt, PharmD; Marcus T. Autry, PharmD; Julia Ye, PharmD Candidate; Phoi Nguyen, PharmD Candidate; Silas Day
Read More
FDA Updates, Lung Cancer
FDA Approves Tepmetko for Metastatic NSCLC and MET Exon 14 Skipping Alterations
Read More
From the Literature, Colorectal Cancer, Screening
Pembrolizumab Shows Long-Term Benefits in Patients with Metastatic Colorectal Cancer and MSI-H or dMMR
Read More
Page 92 of 196
Results 911 - 920 of 1954